Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been assigned an average rating of “Hold” from the eleven research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $5.72.

A number of analysts have recently issued reports on the stock. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a report on Friday, November 8th. BTIG Research assumed coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They set a “buy” rating and a $7.00 target price for the company. Finally, Stephens started coverage on Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price target on the stock.

Definitive Healthcare Stock Up 5.8 %

DH stock opened at $4.36 on Friday. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. The firm has a 50-day moving average of $4.37 and a two-hundred day moving average of $4.58. Definitive Healthcare has a 12 month low of $3.19 and a 12 month high of $10.62. The company has a market cap of $503.68 million, a price-to-earnings ratio of -1.41, a PEG ratio of 3.29 and a beta of 1.40.

Insider Transactions at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the sale, the insider now directly owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 14.84% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Point72 DIFC Ltd increased its position in shares of Definitive Healthcare by 759.9% in the third quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after buying an additional 8,215 shares in the last quarter. Intech Investment Management LLC purchased a new position in Definitive Healthcare during the 3rd quarter valued at about $55,000. Bleakley Financial Group LLC purchased a new position in Definitive Healthcare during the 3rd quarter valued at about $74,000. Glenmede Trust Co. NA raised its position in Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after acquiring an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of Definitive Healthcare in the third quarter valued at about $84,000. 98.67% of the stock is owned by hedge funds and other institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.